Concepedia

Author

David E. Parkin

Aberdeen Royal Infirmary

Also Known As

A.G. Adesuyin, D E Parkin, D Parkin, D. E. PARKIN, D. E. Parkin, D. Parkin, D. Parkin Gynaecological Oncology Unit, D.E. PARKIN, D.E. Parkin, DAVID E. PARKIN

126

Publications

6K

Citations

32

H-Index

115

Concepts

All Affiliations

Aberdeen Royal InfirmaryUniversity of AberdeenWestern InfirmaryStobhill HospitalBeatson West of Scotland Cancer Centre
DE

About

David E. Parkin is an author at Aberdeen Royal Infirmary specializing in medicine, obstetrics, and surgery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

23

33

1.8K

2

Health Sciences

5

5

544

3

Public Health

5

5

172

4

Engineering

1

1

224

5

Humanities

1

1

19

David E. Parkin

×

59

Publications

5.4K

Citations

31

H-Index

YearCitations

Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan

Alan N. Gordon, John Fleagle, David Guthrie,

Journal of Clinical Oncology

2001

1.2K

Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-line Chemotherapy for Ovarian Carcinoma

P. Vasey, Gordon C. Jayson, Amanda Gordon,

JNCI Journal of the National Cancer Institute

2004

624

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

Ignace Vergote, Corneel Coens, Matthew Nankivell,

The Lancet Oncology

2018

290

Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding

S. B. Pinion, David E. Parkin, D. R. Abramovich,

BMJ

1994

280

Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer

Vanessa N. Harry, Scott I. Semple, Fiona J. Gilbert,

Gynecologic Oncology

2008

224

p53 mutation is a common genetic event in ovarian carcinoma.

B J Milner, Lindsey Allan, Diana Eccles,

PubMed

1993

177

Profiling Cytochrome <i>P</i>450 Expression in Ovarian Cancer: Identification of Prognostic Markers

Diane L. Downie, Morag McFadyen, Patrick H. Rooney,

Clinical Cancer Research

2005

164

Comparison of microwave endometrial ablation and transcervical resection of the endometrium for treatment of heavy menstrual loss: a randomised trial

Kevin Cooper, Christine Bain, David E. Parkin

The Lancet

1999

163

Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group.

S.B. Kaye, James Paul, J Cassidy,

Journal of Clinical Oncology

1996

139

Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects

D. A. Alexander, S. B. Pinion, Jill Mollison,

BMJ

1996

133

Page 1